. SIVmac239 that cells, ⌬vif HIV-1 minus-strand reverse transcripts conis deficient in vif (⌬vif), replicates to low titers in infected tained frequent G→A mutations, suggesting a role for macaques and does not cause disease (Desrosiers et cytosine deamination. al., 1998).
We report here that HIV-1 Vif forms a complex with ⌬vif HIV-1 does not replicate in primary T cells, macrohuman APOBEC3G, preventing its encapsidation. HIV-1 phages or some CD4 ϩ transformed T cell lines (termed Vif did not form a complex with mouse APOBEC3G, and "nonpermissive"). In contrast, several transformed T cell as a result, did not prevent its encapsidation. Conselines (termed "permissive") support the replication of quently, mouse APOBEC3G and APOBEC3Gs from AGM ⌬vif HIV-1 (Gabuzda et al., 1992; Strebel et al., 1987;  and rhesus macaque, were potent inhibitors of HIV-1 replication that were resistant to HIV-1 Vif. These findings provide a molecular mechanism for Vif function and have implications regarding the restriction of HIV-1 antiviral property of APOBEC3G is conserved by the mouse protein but that the ability to functionally interact infection to humans and the host factors that influence with Vif is species-restricted, probably reflecting in vivo disease progression in infected individuals.
selective pressure on Vif to adapt to the human enzyme. to HIV-1 Vif was not due to overexpression of the mouse ( Figure 1A ). Mouse APOBEC3G was also active against enzyme (Figure 2 ). Lower molecular weight bands ⌬vif HIV-1. Unexpectedly, the mouse enzyme was that appeared to be degradation products of human equally active against the wild-type virus, reducing APOBEC3G were faintly visible on immunoblots on lyits infectivity Ͼ150-fold in some experiments. Mouse sates of cells in which Vif had been expressed. APOBEC1 and APOBEC2 were inactive ( Figure 1A) as To determine whether mouse APOBEC3G would were human APOBEC3A-F (not shown). The full-length protect cells from productive HIV-1 replication as a remouse APOBEC3G (NIH-3T3 cDNA) and the more comsult of its Vif-resistant phenotype, HOS.CD4.X4 cells mon exon V-deleted (e.g., C57BL/6 cDNA) were similarly were prepared that stably produced human or mouse APOBEC3G and then challenged with wild-type and ⌬vif active ( Figure 1B) . These findings demonstrated that the In contrast, sequences of a 100 bp region 5Ј to the PBS of viral cDNA from newly infected cells showed could account for species-specific restrictions to HIV-1. To determine whether simian APOBEC3G could restrict pronounced differences in mutation frequency that were APOBEC3G and Vif-dependent ( Figure 5A ). Reverse HIV-1, AGM, rhesus macaque and chimpanzee APO-BEC3G were cloned, sequenced, and tested against transcripts that were synthesized by wild-type and ⌬vif virus produced in the absence of APOBEC3G were rarely wild-type and ⌬vif HIV-1, SIVagm, and SIVmac luciferase reporter viruses. Sequences of primate, human, and mutated (0.064%-0.027%). The mutation frequency was slightly higher for wild-type virus produced in the presmouse APOBEC3G are aligned in Figure 4A . Chimpanzee APOBEC3G was most similar to human, differing ence of APOBEC3G (0.6%), consistent with incomplete protection by Vif. The mutation rate was higher for ⌬vif in amino acid sequence by 5%. AGM and macaque APOBEC3G were more divergent, differing from human virus produced in the presence of human APOBEC3G (1.23%) and for wild-type (1.53%) and ⌬vif (0.92%) viby 23% and 25%, respectively, but were 88% identical to one another. The reporter virus analysis showed that ruses produced in the presence of mouse APOBEC3G. Two hot spots for mutation by the mouse and human the three primate APOBEC3Gs were active against ⌬vif HIV-1 ( Figure 4B ). AGM and macaque APOBEC3G, like enzymes contained the sequence TGG. Of the nucleotides changed in the presence of human or mouse APOthe mouse enzyme, were resistant to HIV-1 Vif, blocking wild-type HIV-1. Only the chimpanzee APOBEC3G was BEC3G, 78% and 84% were G→A, respectively. Such changes are consistent with cytosine deamination to sensitive to HIV-1 Vif. Each of the APOBEC3Gs was active against ⌬vif SIVmac and was sensitive to SIVmac uracil in the viral minus-strand cDNA that is subsequently copied as A in the plus strand. Vif. AGM and macaque APOBEC3G were sensitive to SIVagm Vif. Interestingly, human and chimpanzee APO-BEC3G were resistant to AGM Vif. Thus, these enzymes Figures 6A and 6B ). Human the decrease was most pronounced for the ⌬vif-defec-APOBEC3G was detected as an intense band in ⌬vif tive virus. Quantitation of integrated proviruses revealed virions, but was reduced 140-fold in wild-type virions a more pronounced defect. The ⌬vif defective viruses ( Figure 6A ). In contrast, mouse and AGM APOBEC3G generated about 7-fold fewer proviruses than the active were present in virions regardless of whether Vif was viruses ( Figure 5B ). Taken together, these data suggested expressed. In fact, wild-type virions reproducibly conthat deamination of the minus-strands by APOBEC3G durtained 2-3-fold more mouse and AGM APOBEC3G than ing reverse transcription does not interfere with comple⌬vif particles ( Figure 6A ). In cell lysates, Vif caused a tion of cDNA synthesis but that the presence of uracil modest 3-fold reduction in human but not mouse or results in degradation of the molecules prior to inte-AGM APOBEC3G ( Figure 6B) . The most straightforward explanation of these results gration. The coimmunoprecipitation findings demonstrated cytosine in the single-stranded cellular DNA that forms at R loops in the switch regions adjacent to immunoglobthat Vif forms a complex with APOBEC3G. However, the mechanism by which Vif prevents APOBEC3G encapsiulin isotype genes (Honjo et al., 2002) . It is not clear whether APOBEC3G evolved in mamdation is not clear. The presence of low molecular weight APOBEC3G fragments in the presence of Vif and a modmals to counteract retroviral replication or whether the antiviral activity of APOBEC3G is an inadvertent conseest reduction in cellular APOBEC3G were suggestive of Vif-induced degradation. However, pulse-chase analyquence of its physiological function. Rodents are not known to be infected by lentiviruses and thus were under sis showed that Vif did not affect the half-life of human APOBEC3G. Its only effect was a modest (4.6-fold) deno selective pressure to evolve an antilentiviral activity or to maintain this activity through evolution, yet their crease in APOBEC3G synthesis that could have been caused by Vif binding to nascent APOBEC3G, interfering genomes encode an APOBEC3G that blocks lentivirus replication. It is possible that APOBEC3G is incorpowith the completion of its synthesis. Vif-induced degradation of APOBEC3G, although induced to a small exrated into virions because it has affinity for a virion component or because it localizes to cellular sites of virus tent, did not appear to be the primary mechanism by which it blocked APOBEC3G encapsidation. One possiassembly. But whether the property of virion encapsidation was fortuitous or whether it was evolutionarily sebility is that Vif prevents APOBEC3G encapsidation by 
Most of the other rodent APOBEC3Gs shared the

